arrow
C

Carolyn Owen

University of Calgary
H指数:40
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program

blastic plasmacytoid dendritic cell neoplasm (BPDCN):国际、多中心合作和全球登记项目

2025-12-210
OAAI
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis

维奈克拉联合奥比妥珠单抗治疗初治的慢性淋巴细胞白血病患者(体能状态良好):一项加拿大的成本-效用分析

2025-11-010
OA
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

RESONATE-2研究的最终分析:ibrutinib作为CLL/SLL患者一线治疗长达10年的随访研究

Blood
IF23.1
2025-08-050
OAAI
Endo-Histo Foundational Fusion Model: A Novel Artificial Intelligence Approach for Predicting Histologic Remission and Early Response to Therapy in a Phase 2 Ulcerative Colitis Clinical Trial
2025-01-220
PRE
Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up

一线伊布替尼治疗可改善具有高风险基因组特征的慢性淋巴细胞白血病(CLL)患者的总生存率,使其接近于年龄匹配的美国人群水平:基于具有10年随访数据的III期试验的合并分析

BLOOD
IF23.1
2024-11-050
PRE
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
2023-10-1213
OAAI
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia
2023-07-019
OA